The importance of TGF-β in the tumor microenvironment is further highlighted by evidence showing that in several tumor types, including melanoma, lung, pancreatic, colorectal, hepatic and breast, the elevated levels of TGF-β ligand are correlated with disease progression, recurrence, metastasis, and mortality. Here, TGFB1 is linked to neoplasm.